Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Taiwanese (TAIEX) Healthcare Sector Analysis

UpdatedJun 21, 2025
DataAggregated Company Financials
Companies220
  • 7D1.2%
  • 3M-4.4%
  • 1Y-10.8%
  • YTD3.2%

The Healthcare is pretty flat in the last 7 days, but Caliway Biopharmaceuticals has stood out, gaining 24%. As for the longer term, the industry has declined 11% in the last year. Earnings are forecast to grow by 47% annually.

Sector Valuation and Performance

Has the Taiwanese Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 21 Jun 2025NT$1.6tNT$260.9bNT$16.3b19.8x96.6x6x
Mon, 19 May 2025NT$1.5tNT$260.7bNT$16.4b20x90.5x5.7x
Wed, 16 Apr 2025NT$1.4tNT$254.3bNT$12.0b19x114.7x5.4x
Fri, 14 Mar 2025NT$1.6tNT$253.7bNT$12.1b22.1x132.1x6.3x
Sun, 09 Feb 2025NT$1.6tNT$246.5bNT$8.4b23.3x194.1x6.6x
Tue, 07 Jan 2025NT$1.5tNT$245.2bNT$8.6b22.4x177.6x6.2x
Thu, 05 Dec 2024NT$1.6tNT$244.8bNT$8.9b22.6x174.3x6.3x
Sat, 02 Nov 2024NT$1.5tNT$236.6bNT$6.9b25.4x222x6.5x
Mon, 30 Sep 2024NT$1.6tNT$236.4bNT$6.8b24.8x233.6x6.7x
Wed, 28 Aug 2024NT$1.6tNT$236.6bNT$6.8b26.4x238.8x6.9x
Fri, 26 Jul 2024NT$1.7tNT$229.1bNT$3.7b29.1x444.3x7.2x
Sun, 23 Jun 2024NT$1.6tNT$228.6bNT$3.9b27.5x400.6x6.9x
Tue, 21 May 2024NT$1.5tNT$228.7bNT$4.0b26x375.9x6.6x
Thu, 18 Apr 2024NT$1.4tNT$228.6bNT$4.6b26.5x316.7x6.3x
Sat, 16 Mar 2024NT$1.4tNT$227.1bNT$7.0b24.4x202.7x6.2x
Mon, 12 Feb 2024NT$1.4tNT$225.8bNT$6.5b24.7x215.6x6.2x
Wed, 10 Jan 2024NT$1.4tNT$224.9bNT$6.0b24.8x231.9x6.2x
Fri, 08 Dec 2023NT$1.4tNT$224.7bNT$5.9b25.6x238.8x6.3x
Sun, 05 Nov 2023NT$1.4tNT$225.1bNT$7.9b25.2x172.6x6x
Tue, 03 Oct 2023NT$1.4tNT$225.2bNT$8.2b25.7x167.9x6.1x
Thu, 31 Aug 2023NT$1.4tNT$225.2bNT$8.4b25.3x165.4x6.2x
Sat, 29 Jul 2023NT$1.4tNT$227.1bNT$11.5b24.5x123.5x6.3x
Mon, 26 Jun 2023NT$1.4tNT$226.5bNT$11.6b24.4x121.6x6.2x
Wed, 24 May 2023NT$1.5tNT$222.3bNT$12.5b25.2x116.3x6.5x
Fri, 21 Apr 2023NT$1.5tNT$219.7bNT$12.3b22.7x120.4x6.7x
Sun, 19 Mar 2023NT$1.4tNT$217.2bNT$14.0b21.5x98.2x6.3x
Tue, 14 Feb 2023NT$1.4tNT$214.5bNT$13.8b21.7x103x6.6x
Thu, 12 Jan 2023NT$1.3tNT$214.5bNT$13.8b20.1x93x6x
Sat, 10 Dec 2022NT$1.3tNT$214.5bNT$14.1b19x94.6x6.2x
Mon, 07 Nov 2022NT$1.2tNT$209.3bNT$11.4b18.1x102.4x5.6x
Wed, 05 Oct 2022NT$1.2tNT$207.4bNT$10.8b20.2x116.2x6x
Fri, 02 Sep 2022NT$1.4tNT$207.3bNT$10.9b21.3x132.5x7x
Sun, 31 Jul 2022NT$1.3tNT$199.3bNT$9.9b23x128.4x6.4x
Tue, 28 Jun 2022NT$1.2tNT$199.0bNT$9.8b22.3x126.5x6.2x
Price to Earnings Ratio

126.5x


Total Market Cap: NT$1.2tTotal Earnings: NT$9.8bTotal Revenue: NT$199.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Healthcare Sector Price to Earnings3Y Average 180.5x202320242025
Current Industry PE
  • Investors are pessimistic on the Taiwanese Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 96.3x which is lower than its 3-year average PE of 181x.
  • The industry is trading close to its 3-year average PS ratio of 6.3x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 19% per year over the last three years.
  • Revenues for these companies have grown 9.4% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare sector?

TW Market-0.23%
Healthcare1.16%
Pharma3.96%
Life Sciences2.54%
Medical Equipment2.18%
Healthtech-1.02%
Healthcare Services-2.21%
Biotech-2.44%
Industry PE
  • Investors are most optimistic about the Healthtech industry which is trading above its 3-year average PE ratio of 204x.
    • It looks like they are confident that earnings will grow faster in the future than they have historically.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 53% over the next 5 years.
  • This is better than its past earnings growth rate of 13% per year.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 12% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6919 Caliway BiopharmaceuticalsNT$1.24k24.4%
+NT$37.7b		137.1%PS4752.6x
7799 Heron Neutron MedicalNT$685.009.4%
+NT$8.3b		n/aPS420839.8x
6499 Medeon BiodesignNT$126.0013.0%
+NT$1.3b		149.5%PS33.4x
6589 EirGenixNT$65.505.5%
+NT$1.0b		-24.4%PS20.4x
4147 TaiMed BiologicsNT$95.603.2%
+NT$819.4m		7.5%PS43x

Latest News

6589
NT$65.50
EirGenix
7D
5.5%
1Y
-24.4%
6885
NT$38.95
BRIM Biotechnology
7D
18.4%
1Y
-4.8%
6617
NT$96.00
Gongwin Biopharm Holdings
7D
-6.3%
1Y
-40.0%
6446
NT$521.00
PharmaEssentia
7D
-3.2%
1Y
8.0%
6838
NT$39.85
Formosa Pharmaceuticals
7D
11.6%
1Y
-26.2%
6550
NT$37.45
Polaris Group
7D
-6.0%
1Y
-47.1%
4147
NT$95.60
TaiMed Biologics
7D
3.2%
1Y
7.5%
4743
NT$67.00
Oneness Biotech
7D
-12.4%
1Y
-53.6%
1295
NT$116.00
Synbio Tech
7D
11.5%
1Y
76.6%
3218
NT$188.50
Universal Vision Biotechnology
7D
-6.7%
1Y
-24.3%
6499
NT$126.00
Medeon Biodesign
7D
13.0%
1Y
149.5%
6547
NT$44.40
Medigen Vaccine Biologics
7D
-4.6%
1Y
-14.9%
6919
NT$1,240.00
Caliway Biopharmaceuticals
7D
24.4%
1Y
137.1%
6535
NT$152.00
Lumosa Therapeutics
7D
-7.6%
1Y
-31.5%
6620
NT$79.20
Handa Pharmaceuticals
7D
-7.9%
1Y
-26.7%
7799
NT$685.00
Heron Neutron Medical
7D
9.4%
1Y
n/a